Corthera
San Carlos
About Corthera
Corthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $40.1M
- Funding stage: M&A
- Last round: Series C (Dec 2007)
- Website: corthera.com
- Phone: +1 650-235-3555
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/corthera-3397431 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.